|
| Targeting proteostasis and autophagy in SMARCB1-deficient malignancies: where next? |
|
https://doi.org/10.18632/oncotarget.26970
Pavlos Msaouel, Alessandro Carugo, Giannicola Genovese
|
| 3979-3981 |
|
| The non-random landscape of somatically-acquired uniparental disomy in cancer |
|
https://doi.org/10.18632/oncotarget.26987
Pau Erola, Keyvan Torabi, Rosa Miró, Jordi Camps
|
| 3982-3984 |
|
| Cancer vaccines: what’s next? |
|
https://doi.org/10.18632/oncotarget.27006
Stéphane Depil, Paola Bonaventura, Vincent Alcazer
|
| 3985-3987 |
|
| VEGF-C as a putative therapeutic target in cancer |
|
https://doi.org/10.18632/oncotarget.27007
Signe R. Michaelsen, Hans S. Poulsen, Petra Hamerlik
|
| 3988-3990 |
|
| Diffuse large B-cell lymphoma: the stuff of cell-of-origin and microenvironment |
|
https://doi.org/10.18632/oncotarget.27013
Stefano A. Pileri, Maria Carmela Vegliante, Sabino Ciavarella
|
| 3991-3993 |
|
| Advanced MRI in neuro-oncology: can we proceed without inclusion of energy metabolism? |
|
https://doi.org/10.18632/oncotarget.27015
Andreas Stadlbauer, Michael Buchfelder, Arnd Dörfler, Stefan Oberndorfer
|
| 3994-3995 |
|
| Mesothelioma: Hippo pathway as a target, lessons from COMMAND |
|
https://doi.org/10.18632/oncotarget.27018
Dean A. Fennell, Essa Y. Baitei
|
| 3996-3997 |
|
| From rare to well-done: importance of rare tumors in cancer therapeutic advances |
|
https://doi.org/10.18632/oncotarget.27020
Florence Duffaud, Sophie Piperno-Neumann, Nicolas Penel, Jean-Yves Blay
|
| 3998-3999 |
|
| An emerging role of CD9 in stemness and chemoresistance |
|
https://doi.org/10.18632/oncotarget.27021
Mujib Ullah, Asma Akbar, Avnesh S. Thakor
|
| 4000-4001 |
|
| Targeted therapy in CLL: changing the treatment paradigm |
|
https://doi.org/10.18632/oncotarget.26964
|
| 4002-4003 |
|
| ETHE1 overexpression promotes SIRT1 and PGC1α mediated aerobic glycolysis, oxidative phosphorylation, mitochondrial biogenesis and colorectal cancer |
|
https://doi.org/10.18632/oncotarget.26958
Mavee Witherspoon, Davinder Sandu, Changyuan Lu, Kehui Wang, Robert Edwards, Anthony Yeung, Ozkan Gelincik, Giovanni Manfredi, Steven Gross, Levy Kopelovich, Steven Lipkin
|
| 4004-4017 |
|
| Prevalence of established and emerging biomarkers of immune checkpoint inhibitor response in advanced hepatocellular carcinoma |
|
https://doi.org/10.18632/oncotarget.26998
Celina Ang, Samuel J. Klempner, Siraj M. Ali, Russell Madison, Jeffrey S. Ross, Eric A. Severson, David Fabrizio, Aaron Goodman, Razelle Kurzrock, James Suh, Sherri Z. Millis
|
| 4018-4025 |
|
| Somatic molecular analysis augments cytologic evaluation of pancreatic cyst fluids as a diagnostic tool |
|
https://doi.org/10.18632/oncotarget.26999
Ali Sakhdari, Parnian Ahmadi Moghaddam, Chi Young Ok, Otto Walter, Keith Tomaszewicz, Mandi-Lee Caporelli, Xiuling Meng, Jennifer LaFemina, Giles Whalen, Edward Belkin, Jaroslav Zivny, Wahid Wassef, Bruce A. Woda, Lloyd M. Hutchinson, Ediz F. Cosar
|
| 4026-4037 |
|
| Mutations of the MAPK/TSC/mTOR pathway characterize periventricular glioblastoma with epithelioid SEGA-like morphology–morphological and therapeutic implications |
|
https://doi.org/10.18632/oncotarget.27005
Maria-Magdalena Georgescu, Yan Li, Mohammad Zahidul Islam, Christina Notarianni, Hai Sun, Adriana Olar, Gregory N. Fuller
|
| 4038-4052 |
|
| Impact of eIF4E phosphorylation at Ser209 via MNK2a on tumour recurrence after curative surgery in localized clear cell renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.27017
Osamu Ichiyanagi, Hiromi Ito, Sei Naito, Takanobu Kabasawa, Hidenori Kanno, Takafumi Narisawa, Masaki Ushijima, Yuta Kurota, Michinobu Ozawa, Toshihiko Sakurai, Hayato Nishida, Tomoyuki Kato, Mitsunori Yamakawa, Norihiko Tsuchiya
|
| 4053-4068 |
|
| Neoadjuvant nimotuzumab plus chemoradiotherapy compared to neoadjuvant chemoradiotherapy and neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma |
|
https://doi.org/10.18632/oncotarget.23861
|
| 4069-4078 |
|
| Correction: Glucocorticoid impairs cell-cell communication by autophagy-mediated degradation of connexin 43 in osteocytes |
|
https://doi.org/10.18632/oncotarget.27035
Junjie Gao, Tak Sum Cheng, An Qin, Nathan J. Pavlos, Tao Wang, Kai Song, Yan Wang, Lianzhi Chen, Lin Zhou, Qing Jiang, Hiroshi Takayanagi, Sheng Yan, Minghao Zheng
|
| 4079-4079 |
